Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System (NCT06735534)
The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters
🩺 Plain-English Summary (8th-Grade Level)
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
Who can join: Review the eligibility criteria below.
Location: Mobile Infirmary Medical Center — Mobile, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (41 Sites)
Showing the first 25 of 41 sites.
- Mobile Infirmary Medical Center — Mobile, Alabama
- Arrhythmia Research Group-Research Facility — Jonesboro, Arkansas
- University of Southern California Hospital — Los Angeles, California
- St. John's Regional Medical Center — Oxnard, California
- Stanford University Medical Center — Stanford, California
- South Denver Cardiology Associates, PC — Littleton, Colorado
- HCA Florida Mercy Hospital — Miami, Florida
- Naples Comprehensive Health — Naples, Florida
- AdventHealth Orlando-Hospital — Orlando, Florida
- Tampa General Hospital — Tampa, Florida
- AdventHealth Tampa-Hospital — Tampa, Florida
- Emory University Hospital — Atlanta, Georgia
- Atrium Health Navicent The Medical Center — Macon, Georgia
- Memorial Health University Medical Center — Savannah, Georgia
- St. Luke's Boise Medical Center — Boise, Idaho
- Advocate Christ Medical Center-Hospital — Oak Lawn, Illinois
- Johns Hopkins Hospital — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- Southcoast Physicians Group — Fall River, Massachusetts
- William Beaumont Hospital-Hospital — Royal Oak, Michigan
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
- Virtua Health Inc. — Marlton, New Jersey
- Lovelace Medical Center — Albuquerque, New Mexico
- Northwell Health — Manhasset, New York
- Weill Cornell Medical University — New York, New York
📞 Contact the Study Coordinator
Phone: (612) 417-9538
Email: Kristin.Mathson@bsci.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Persistent Atrial Fibrillation
- Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Jonesboro, Arkansas
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
- SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
- Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
- STOP Persistent AF PAS — Hartford, Connecticut
- REPRESENT-PF Registry — New York, New York
Explore by condition: All Persistent Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.